Skip to main content

Table 3 Serum 25(OH)VD levels in CHC patients at baseline and after DAA curative treatment comparing cirrhotic and non-cirrhotic patients

From: Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy

 

Week 0 (ng/mL)

Week 24 (ng/mL)

Week 48a (ng/mL)

Cirrhotic (n = 63)

25.0 ± 10.5

20.2 ± 8.1

19.9 ± 8.2

Non-cirrhotic (n = 17)

31.0 ± 10.3

22.8 ± 7.7

24.1 ± 9.4

p value

0.039

0.251

0.087

  1. aSix patients were lost to follow-up at 48 weeks; 5 in cirrhotic group and 1 in non-cirrhotic group